Table 1.
Patient characteristics.
| N | 68 | Pulmonary function test | ||
| Diskus preceding; 35 | IC (L) | 2.26 ± 0.63 | ||
| Aerosol preceding; 33 | FVC (L) | 3.18 ± 0.95 | ||
| Male:female | 32:36 | %FVC (%) | 101.8 ± 16.1 | |
| Age (years old) | 62.1 ± 15.6 | FEV1 (L) | 2.24 ± 0.71 | |
| Height (cm) | 161.6 ± 9.3 | %FEV1 (%) | 88.6 ± 17.6 | |
| Body weight (kg) | 62.2 ± 12.6 | Post-BD FEV1 (L) | 2.36 ± 0.73 | |
| BMI (kg/m2) | 23.7 ± 3.7 | %Post-BD FEV1 (%) | 92.9 ± 16.7 | |
| Smoking | Never; 42 (61.8%) | Previous medications | ||
| Ex-smoker; 26 (38.2%) | ICS/LABA | SFC (DPI) | 41 | |
| Pediatric asthma | 12 (17.6%) | SFC (pMDI) | 20 | |
| Disease duration (y) | 10.5 ± 10.9 | FBC | 2 | |
| Allergic comorbidities | Allergic rhinitis; 39 (57.4%) | CIC + Sal | 3 | |
| Hay fever; 32 (47.1%) | ICS | Mo | 1 | |
| FP | 1 | |||
| ACT | 22.8 ± 2.7 (median; 24) | Concomitant | LTRA | 32 |
| TEO | 4 | |||
| Other | 12 | |||
| Pinch meter (kg) | 7.0 ± 2.1 | Device type | pMDI | 20 |
| PIF (adaptor-free, L/min) | 216.9 ± 77.7 | DPI | 45 | |
| (A/A/D, L/min) | 92.3 ± 26.2 | Both | 3 | |
BMI: body mass index; ACT: Asthma Control Test; A/A/D: adapter for Diskus® resistance; PIF: peak inspiratory flow; IC: inspiratory capacity; FVC: forced vital capacity; FEV1: forced expiratory volume in the first second; BD: bronchodilator; ICS: inhaled corticosteroid; LABA: long-acting β-agonist; SFC: salmeterol/fluticasone combination; DPI: dry powder inhaler; pMDI: pressurized metered-dose inhaler; FBC: formoterol/budesonide combination (DPI); CIC: ciclesonide (pMDI); Sal: salmeterol (DPI); Mo: mometasone (DPI); FP: fluticasone propionate (DPI); LTRA: leukotriene receptor antagonists; TEO: theophylline.